Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem
EuroIntervention 2015;11:e1 published online e-article August 2015. DOI: 10.4244/EIJV11I4A88
Nicolas Foin1, MSc, PhD; Renick Lee1, BEng; Philip Wong1, MD; Adrian F. Low2*, MD
1. National Heart Centre Singapore, Singapore; 2. National University Heart Centre Singapore, Singapore
A 62-year-old man had stenting of the proximal left anterior descending artery with a 3.5×23 mm CYPHER® drug-eluting stent (DES) (Cordis, Johnson & Johnson, Warren, NJ, USA) 10 years ago. He presented with unstable angina. Optical coherence tomography (OCT) revealed evidence of neoatherosclerosis and a minimal luminal area (MLA) of 2.08 mm2 as well as evagination with extensive late stent malapposition (Figure 1A-Figure 1C, Moving image 1).
Figure 1. Very late metallic stent thrombosis and in-stent restenosis treated with a BVS. A) In-stent restenosis and focal aneurysm in the left anterior descending artery around the sirolimus DES implanted for 10 years. B) Neointimal proliferation ...